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Neurobiology of Disease
Regulation of Cytoplasmic Dynein ATPase by Lis1
Mariano T. Mesngon,1 Cataldo Tarricone,3 Sachin Hebbar,1 Aimee M. Guillotte,1 E. William Schmitt,2 Lorene Lanier,4
Andrea Musacchio,3 Stephen J. King,2 and Deanna S. Smith1
1Department of Biological Sciences, University of South Carolina, Columbia, South Carolina 29208, 2Division of Molecular Biology and Biochemistry,
University of Missouri–Kansas City, Kansas City, Missouri 64110, 3Department of Experimental Oncology, European Institute of Oncology, 20141 Milan,
Italy, and 4Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455
Mutations in Lis1 cause classical lissencephaly, a developmental brain abnormality characterized by defects in neuronal positioning.
Over the last decade, a clear link has been forged between Lis1 and the microtubule motor cytoplasmic dynein. Substantial evidence
indicates that Lis1 functions in a highly conserved pathway with dynein to regulate neuronal migration and other motile events. Yeast
two-hybrid studies predict that Lis1 binds directly to dynein heavy chains (Sasaki et al., 2000; Tai et al., 2002), but the mechanistic
significance of this interaction is not well understood. We now report that recombinant Lis1 binds to native brain dynein and significantly
increases the microtubule-stimulated enzymatic activity of dynein in vitro. Lis1 does this without increasing the proportion of dynein that
binds to microtubules, indicating that Lis1 influences enzymatic activity rather than microtubule association. Dynein stimulation in vitro
is not a generic feature of microtubule-associated proteins, because tau did not stimulate dynein. To our knowledge, this is the first
indication that Lis1 or any other factor directly modulates the enzymatic activity of cytoplasmic dynein. Lis1 must be able to homodimer-
ize to stimulate dynein, because a C-terminal fragment (containing the dynein interaction site but missing the self-association domain)
was unable to stimulate dynein. Binding and colocalization studies indicate that Lis1 does not interact with all dynein complexes found
in the brain. We propose a model in which Lis1 stimulates the activity of a subset of motors, which could be particularly important during
neuronal migration and long-distance axonal transport.
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Introduction
Lissencephalies are developmental abnormalities characterized
by reduced brain folding, cognitive impairment, and progres-
sively worsening epileptic seizures (Kato and Dobyns, 2003).
Heterozygous disruption of the Lis1 gene causes type 1 lissen-
cephaly. Postmortem cytohistological studies indicate that neu-
rons are aberrantly positioned in affected regions. Lis1 haploin-
sufficiency in mice results in defective interkinetic nuclear
migration in the ventricular zone and slowed neuronal migration
in the developing cortex (Hirotsune et al., 1998; Gambello et al.,
2003). Total loss of Lis1 is lethal in mouse embryogenesis (Hirot-
sune et al., 1998; Cahana et al., 2003).
Significant progress has been made in elucidating the cellular
processes regulated by Lis1 (Vallee et al., 2001; Wynshaw-Boris
and Gambello, 2001; Gupta et al., 2002; Xiang, 2003). Although
Lis1 is enriched in the brain (Smith et al., 2000), Lis1 function is
not restricted to the nervous system. Mutations in the highly
conserved Lis1 protein profoundly impact migration, nuclear
distribution, and mitosis in a range of organisms from yeast to
mammals. However, the sensitivity of neurons to Lis1 reduction
points to a unique importance in these cells, effecting not only
migration and mitosis but neuritic structure, axon transport, and
synaptic function (Liu et al., 2000; Williams et al., 2004).
The C terminus of Lis1 folds to form a -propeller as do many
proteins with short 40 aa repeated motifs that end in Trp-Asp
(WD) (Kim et al., 2004; Tarricone et al., 2004). Lis1 dimerizes
through a self-association domain in the N terminus. Lis1 may
interact directly with tubulin and/or microtubules (MTs) (Sapir
et al., 1999). Although the list of potential Lis1-interacting pro-
teins continues to grow, an important key to understanding the
role of Lis1 in development and disease is its association with a
multisubunit motor protein, cytoplasmic dynein (Smith et al.,
2000; Vallee et al., 2001; Wynshaw-Boris and Gambello, 2001;
Gupta et al., 2002; Xiang, 2003), which has critical functions in
intracellular transport, mitosis, migration, and nuclear position-
ing (Banks and Heald, 2001; Dujardin and Vallee, 2002; Tsai and
Gleeson, 2005). Dynein performs microtubule-dependent ATP
hydrolysis to translocate toward microtubule minus ends. In
neurons, cytoplasmic dynein is the predominant motor for long-
distance retrograde transport in axons (Goldstein and Yang,
2000) and has been linked to neurodegenerative diseases involv-
ing defects in transport (Hirokawa and Takemura, 2004). Dynein
is a protein complex. Dynein heavy chains (DHCs) are ATPases,
whereas dynein intermediate chains (DICs), dynein light chains
(DLCs), and dynein light intermediate chains (LICs) confer cargo
specificity and subcellular targeting. Despite intense scrutiny
over the last decade, relatively little is understood about the
mechanistic significance of the Lis1/dynein association. Our
work, analyzing the impact of altering Lis1 expression in non-
neuronal cells, strongly suggested a stimulatory role for Lis1 with
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respect to cytoplasmic dynein (Smith et al., 2000). We now report
that Lis1 stimulates the average in vitro enzymatic activity of dynein
by 40%. Other evidence indicates that a subpopulation of brain
dynein binds Lis1. Together, these data suggest that ATPase activity
is substantially higher for dynein motors that interact with Lis1. We
propose that modulation of the Lis1-dynein interaction serves as a
control point in motor regulation.
Materials and Methods
Antibodies. A rabbit IgG against Lis1 was used in
Figure 5B (H300; Santa Cruz Biotechnology,
Santa Cruz, CA); otherwise, an affinity-purified
rabbit Lis1 antibody was used (Smith et al.,
2000). Other antibodies used were as follows:
mouse DIC and rabbit DHC antibodies (IgG
74.1, R-325; Santa Cruz Biotechnology) and
mouse -tubulin (clone B-5-1-2; Sigma, St.
Louis, MO).
Protein isolation. Full-length recombinant
Lis1 and a fragment of Lis1 encompassing the
WD domain (amino acids 51– 410) were pro-
duced as histidine-tagged proteins in Sf9 insect
cells and purified on Ni-NTA resin (Invitrogen,
Carlsbad, CA) (see Fig. 1). The tag was cleaved
using TEV (tobacco etch virus) protease, de-
signed for use with the Ni-NTA system. The
released Lis1 was dialyzed against Tris-buffered
saline and then stored at 20°C in 50% glyc-
erol. Cytoplasmic dynein was purified from
fresh bovine brains as described previously
(Bingham et al., 1998). Single-use aliquots of
dynein were stored frozen at 80°C. The 4L
longest splice variant of tau was expressed in
bacteria and purified as described previously
(Paudel and Li, 1999). Tau was flash frozen and
stored at 80°C until use.
ATPase assay. A thin-layer chromatography
(TLC) assay (Gilbert and Mackey, 2000) was
modified for use with our purified cytoplasmic
dynein (see Fig. 2 A, B,D). The amount of radio-
labeled ADP generated after 30 min in the pres-
ence or absence of microtubules and/or Lis1
was used as an indication of enzymatic activity.
Reaction volumes were 50 l in BrB80 (80 mM
PIPES, 1 mM EGTA, 1 mM MgCl2). Equimolar
amounts of purified Lis1 and dynein (5 pmol)
were incubated at 37°C for 30 min with 10 Ci
- 32P-ATP with or without 8 M paclitaxel-
stabilized microtubules. Microtubules were
prepared from bovine brain tubulin (Cytoskel-
eton, Denver, CO) as described below. The re-
action mixture was centrifuged at 13 K rpm for
2 min. Totals of 0.2– 0.6 l of the supernatants
were spotted onto PEI-Cellulose F TLC plates
(EMD Chemicals, Gibbstown, NJ). TLC plates
were developed in 0.6 M potassium phosphate
buffer, pH 3.4. ATP and ADP spots were quanti-
fied densitometrically using Quantity One soft-
ware (Bio-Rad, Hercules, CA) and by scintillation
counting of spots excised from TLC plates.
Comparison of microtubules in the presence
of dynein alone or in the presence of both dy-
nein and Lis1. Purified bovine tubulin (Cy-
toskeleton) was incubated at a concentration
of 5 mg/ml in ice-cold BRB80 (80 mM PIPES,
1 mM MgCl2, 1 mM EGTA, pH 6.8), 1 mM
DTT, 1 mM GTP, and 2.5 g of rhodamine-
labeled tubulin (Cytoskeleton) for 2 min at
0°C and then clarified in a Beckman TLA
120.2 rotor (Beckman Instruments, Fuller-
ton, CA) at 94,000 rpm for 5 min at 4°C. The clarified mix was
incubated at 37°C for 2 min. Taxol was added stepwise to equimolar
concentrations (5, 50, and 500 M) at 1/10 the volume of the clarified
mix and incubated for 5 min at 37°C between each Taxol addition.
Polymerized microtubules were pelleted through a warm 40% glyc-
erol cushion in a Beckman TLA 120.2 rotor at 94,000 rpm for 5 min at
37°C. The microtubules were then washed in BRB80 and 50 M Taxol
Figure 1. Proteins used in the assays. A, A 45 kDa Lis1 band is observed in the purified recombinant Lis1 preparation by silver
staining (lane 1), by Western blotting with a Lis1 antibody (lane 2), or by Coomassie staining (L in F ). B, Western blots of 1 g of
recombinant Lis1 probed for the dynactin subunit p150glued, the dynein intermediate chain, -tubulin, and Ndel1; these pro-
teins are undetectable in the Lis1 preparation. Adult mouse brain extract was used as a positive control (br). C, Histidine-tagged
Lis1 (H-Lis1) immobilized on Ni-NTA resin binds specifically to a known interacting protein, the 2 subunit of PAFAH1b (2),
indicating that the recombinant Lis1 produced in insect cells is correctly folded. D, Multiple bands that correlate by size to known
dynein subunits are visualized in our dynein preparation by Coomassie staining (lane 1). HC, Heavy chain; IC, intermediate chain;
LIC, light intermediate chain. HC and IC are labeled with antibodies specific to those subunits (lanes 2 and 3, respectively). E,
Dynein (dyn; 1 g) did not contain detectable levels of -tubulin (top), nor did it contain Lis1, p150glued (p150), or the Lis1
binding protein Ndel1 (bottom) as detected by Western blotting. F, A fragment of Lis1 encompassing the WD domain (WD) was
visualized by Coomassie staining along with the 4L longest splice variant of tau (t). Protein molecular weights used throughout were 1.2
MDa for dynein, 90 kDa for Lis1 homodimers, 40 kDa for WDLis1, and 65 kDa for monomeric tau. G, Microtubules were not affected by the
presence of Lis1. Microtubule bundling was apparent in both mixtures, because individual structures varied in width. The thinnest struc-
tures, probably representing individual microtubules, aligned frequently to form thicker structures, probably bundles of two to six
microtubules.
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and resuspended in BRB80 and 50 M Taxol
to a final tubulin concentration of 5 mg/ml.
Microtubules and dynein/ Lis1 were in-
cubated as described above for the ATPase
assay, except that no radiolabeled ATP was
included. Five microliters of the reaction mix
were spotted onto a glass coverslip coated
with polylysine to promote sticking. Cover-
slips were mounted using ProLong Gold (In-
vitrogen) and visualized with a plan-apo
63/1.40 objective on an AxioVert 200 in-
verted microscope using a narrow bandpass
filter (41004; Chroma Technology, Rocking-
ham, VT).
Western blotting. Proteins separated by SDS-
PAGE and transferred to PVDF membranes
were blocked in PBST (100 mM phosphate
buffer, pH 8, 150 mM NaCl, 0.1% Tween 20)
containing 5% powdered milk and then incu-
bated with indicated primary antibodies for 1 h
at room temperature (see Figs. 1– 4). Blots were
probed with HRP-conjugated secondary anti-
bodies (Pierce, Rockford, IL). HRP activity was
detected using Western Lightning chemilumi-
nescence reagents (Pierce).
Density sedimentation. Bovine brain dynein
(5 pmol) was incubated with 15 pmol of Lis1 for
30 min at 37°C (see Fig. 3A). For controls, each
protein was incubated alone under the same
conditions. Standards were BSA (3.3S), catalase
(11.4S), and thyroglobulin (19.1S). Proteins
were layered onto 5–25% sucrose gradients and
centrifuged at 130,000  g for 8 h at 4°C. Six-
teen 50 l fractions were collected. Western
blots of fractions 3–12 were probed for Lis1,
DIC, and DHC.
Immunoprecipitation of purified proteins. 1.8
pmol of dynein was incubated with 10 pmol of
Lis1 for 30 min at 37°C in PHM-T buffer (60
mM PIPES, 25 mM HEPES, 4 mM MgSO4 0.1%
Tween 20, pH 6.9) (see Fig. 3B–E). For controls,
each protein was incubated alone. Samples were
exposed to DIC or Lis1 antibodies for 1 h at 4°C.
Protein A-Sepharose (Zymed, San Francisco,
CA) was added, and after rocking for 1 h at 4°C,
beads were washed three times in 150 mM phosphate buffer containing
200 mM NaCl, 0.1% Tween 20, and 0.1 or 1.0% Triton X-100.
Immunoprecipitation from rat tissues. Extracts from brain, liver, and
testes of 3-week-old male rats were dounce-homogenized in lysis buffer
(50 mM HEPES, pH 7.0, 150 mM NaCl, 0.1% NP-40, 2% protease inhib-
itor cocktail III; Calbiochem, La Jolla, CA) at 4°C (see Fig. 4). Lysates
were clarified at 28,000  g for 25 min and then incubated for 1 h with
74.1 at 4°C, followed by 1 h with protein A-Sepharose at 4°C. Beads were
washed three times in lysis buffer with 0.1% Tween 20 and 0.1% Triton
X-100 and then resuspended in 1 sample buffer.
Copelleting of dynein with microtubules in the presence or absence of Lis1.
Taxol-stabilized microtubules were prepared in the same manner as de-
scribed for the ATPase assay (see Fig. 2C). 2.5 pmol of Lis1 or Dynein (or
both) was incubated with 2 M Taxol, 2 mM GTP, 1 mM ATP, 8 M casein,
and 8 M microtubules at 33°C for 20 min. Samples were pelleted
through a 40% glycerol cushion at 37°C for 5 min at 94,000 rpm in a
Beckman TLA120.2 rotor. The pellets were resuspended in BRB80 and
then placed on ice for 20 min to disrupt microtubules. The proteins in the
soluble and pelleted fractions were concentrated by chloroform-
methanol precipitation (Wessel and Flugge, 1984). The samples were
analyzed by SDS-PAGE and Western blotting.
Analysis of Lis1 to dynein ratio in the insoluble fraction of mouse tissues.
Mouse tissues were homogenized in lysis buffer as described above (see
Fig. 4C). After centrifugation at 28,000  g, the pellets were resuspended
in 1 SDS sample buffer. A proportional amount of soluble and insolu-
ble fractions were analyzed. For example, the brain sample was lysed in
0.5 ml, and the insoluble pellet was resuspended in 0.1 ml. Five percent of
the soluble fraction and 20% of the insoluble fraction were loaded on the
same gel. The ratio of insoluble to soluble protein obtained by densitom-
etry was then multiplied by four to obtain an estimate of the true
distribution.
Cell culture, fixation, and immunofluorescence. Cos-7 cells maintained
in DMEM with 10% fetal calf serum, L-glutamine, and penicillin and
streptomycin were plated onto 12 mm glass coverslips in 24-well plates
(see Fig. 5). Cells were exposed for 1 min to 0.25% Triton X-100 and 1.0
M paclitaxel in PHEM buffer (120 mM PIPES, 50 mM HEPES, 20 mM
EGTA, 4 mM magnesium acetate, pH 6.9) and then fixed in 3% parafor-
maldehyde for 20 min, followed by 4 min in cold 100% methanol. The
cell in Figure 5B was fixed in cold 100% methanol for 2 min. Hippocampi
were dissected from embryonic day 17 (E17) rats essentially as described
by Goslin et al. (1998). Dissociated neurons were plated onto glass cov-
erslips coated with 1 mg/ml poly-D-lysine and incubated for 48 h. Neu-
rons were fixed in 2% paraformaldehyde for 15 min and then permeabil-
ized for 10 min in PHEM buffer containing 0.1% Triton X-100. Neurites
were considered axons when twice as long as other processes and with
growth cones twice the diameter of the soma (Deitch and Banker, 1993).
After 1 h in block (PHEM with 10% normal goat serum and 3% bovine
serum albumin), coverslips were incubated with primary antibodies and
Figure 2. Recombinant Lis1 specifically and directly increases the enzymatic activity of bovine brain dynein. A, Equimolar Lis1
and dynein were used in an in vitro ATPase assay. ATPase hydrolysis was analyzed using TLC to separate radiolabeled ADP from
ATP. Spots on TLC plates were excised, and total counts per spot were determined by scintillation counting. Data are the mean
(SE) of three separate experiments. Con, Control; M, microtubules; D, dynein; L, Lis1; DL, dynein plus Lis1; DM, dynein plus
microtubules; DML, dynein plus microtubules plus Lis1. The mean of DML is significantly different from the mean of DM (*p 
0.001 as determined by ANOVA statistical analysis). B, Dose–response data for Lis1 indicate our assays are in or near the linear
range for Lis1 activity. The data represent the mean (SE) of four data sets. C, Microtubule copelleting assay: Western blots of
soluble (S) and pelleted (P) fractions,  MTs were probed for Lis1 or DIC. The amount of DIC in the pellet relative to the soluble
fraction is not increased by the presence of Lis1 (two lanes on the right). D, Additional control ATPase assays were performed with
the WD repeat domain of Lis1 (WD) and with tau, an axon-enriched MAP. All reactions contained dynein and microtubules. The
data are presented as the percentage of Lis1 stimulation and are the mean  SE of three separate experiments. Neither WD nor
tau stimulated dynein to the same extent as full-length Lis1 (L). In fact, tau reduced the microtubule-stimulated dynein activity.
WDLis1 blocked stimulation of dynein by full-length Lis1 (LWD).
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then FITC- or Texas Red-conjugated goat -rabbit or -mouse IgG.
Nuclei were labeled with 50 g/ml bizbenzamide for 5 min. Coverslips
were mounted using Prolong Gold (Invitrogen).
Fluorescence microscopy. Fluorescent cells were visualized with a Zeiss
(Thornwood, NY) Axiovert 200 inverted microscope using a plan-neo
objective (100/1.30) or a plan-apo 63/1.40 objective (see Fig. 5). HQ
series Chroma Technology filters sets (41004 and 41001) were used for dou-
ble labeling with FITC- or Texas Red-conjugated secondary antibodies be-
cause of the steeper passbands and decreased bleedthrough. A standard filter
set (31000) was used for bizbenzamide staining. Digital images were ac-
quired with an AxioCam HR CCD camera and AxioVision 4.3 software.
Estimating the degree of Lis1 and dynein colocalization in Cos7 cells.
Using the 63 objective, 10 –16 optical sections were obtained from
interphase Cos7 cells stained for Lis1 and DIC with the AxioVision 4.3
data acquisition module and the AxioVert 200 motorized microscope
(see Fig. 5B). Images were deconvolved using a combined iterative algo-
rithm supplied with the AxioVision 3D deconvolution module. A vol-
ume rendering was generated using the AxioVision Inside4D module,
and an image was saved as a TIFF file for subsequent analysis in Adobe
Photoshop (Adobe Systems, San Jose, CA). The punctate nature of over-
lapping Lis1 and dynein signals in one of these TIFF images is shown in
Figure 5B. To simplify counting of overlapping and nonoverlapping
puncta, yellow (overlapping) pixels were selected in Adobe Photoshop and
replaced with a blue color. The image was then inverted, so the background
became white, and overlapping and nonoverlapping puncta were more
readily visualized (see Fig. 5B). Four images, containing three cells each, were
printed. These were analyzed by manually counting using gridlines as shown
in Figure 5B. The total number of green (dynein), orange (Lis1), and blue
(both) spots was determined for each grid area. These were used to calculate
the average percentage of dynein-positive puncta that were also positive for
Lis1. For each data point, 12 cells were analyzed.
Results
Lis1 stimulates dynein enzymatic activity in vitro
To determine whether Lis1 could modulate dynein enzymatic
activity, we used an in vitro thin-layer chromatography assay with
purified dynein and recombinant Lis1. Figure 1 shows the char-
acterization of the isolated proteins used throughout this study.
Cytoplasmic dynein exhibited modest activity, 68 (9) nmol
ATP hydrolyzed/mg of dynein/min (Fig. 2A). As expected from
published results, dynein activity was increased fourfold by the ad-
dition of stabilized microtubules to 281(19) nmol/mg/min. Lis1
alone did not possess any intrinsic enzymatic activity, but the addi-
tion of equimolar Lis1 increased the microtubule-stimulated AT-
Pase activity of dynein by 40%, to 389 (15) nmol/mg/min. Dou-
bling the Lis1 concentration did not further augment activity,
whereas reducing the Lis1 concentration by 50% resulted in a
smaller stimulation, indicating that the assay was performed within
the linear range for Lis1 activity (Fig. 2B). The recombinant Lis1
used in our assay was properly folded, because the same Lis1 prepa-
ration was used for x-ray crystallography (Tarricone et al., 2004).
Moreover, we found that Lis1 bound at the expected stoichiometry
to PAFAH1b 2, a known binding partner (Fig. 1C).
Lis1 reportedly interacts with tubulin and possibly with microtu-
Figure 3. Lis1 binds to a subset of cytoplasmic dynein motors in vitro. A, Fifteen picomoles of Lis1, 5 pmol of dynein, or a mixture of the two were loaded onto separate 5–25% sucrose gradients,
as indicated (left). Fractions were probed with Lis1, DIC, or DHC antibodies as indicated (right). In the combined sample, 1.7 pmol of Lis1 had shifted to higher fractions, where it cofractionated
with DIC and DHC. No Lis1 was found in denser fractions in the absence of dynein, even when the blot was exposed overnight (long exp.). B, One picomole of dynein coimmunoprecipitated 0.37
pmol of Lis1. L, Lis1; D, dynein; DL, Lis1 and dynein; No Ab, no antibody control; 5% input, 5% of DL. C, No difference was observed when 74.1 IPs were performed in the presence of excess ATP or
ADP. D, The amount of DHC and DIC coprecipitating with Lis1 (L) when dynein (D) is present at a twofold molar excess is visualized by Coomassie staining. IgG is an antibody band. E, Left, Purified
Lis1 and dynein (dyn) probed with Lis1 and dynein antibodies. Right, 2.5 pmol of Lis1 was incubated with 2, 10, and 20 pmol of purified dynein and then precipitated with Lis1 antibodies (Lis1 IP).
Western blots were probed for Lis1 and DIC. The ratio of Lis1 to dynein in each IP was 0.37, 1.2, and 1.3, indicating that dynein binding had saturated when 10 pmol was present. All experiments were
repeated with similar results. Representative blots or gels are shown.
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bules (Sapir et al., 1999). We reasoned that Lis1 could promote dy-
nein association with microtubules, or alter microtubules them-
selves, to indirectly increase ATP hydrolysis. Two pieces of data
indicate that this is not the case. First, Lis1 did not increase the per-
centage of dynein that bound to microtubules (Fig. 2C) (see Mate-
rials and Methods). Second, we observed no Lis1-dependent change
in MT length or bundling (Fig. 1G). Another concern is that any
microtubule-associated protein (MAP) would stimulate dynein in
vitro. Another microtubule binding protein, tau, has been shown to
influence axon transport (Seitz et al., 2002). We therefore tested
recombinant, full-length tau in our assay. Tau did not stimulate
dynein activity, indicating that the Lis1 effect is specific. In fact, tau
significantly reduced the impact of microtubules on dynein activa-
tion (Fig. 2D).
We next determined whether the C-terminal domain of Lis1,
which contains a putative dynein binding domain but not a self-
association domain (Tarricone et al., 2004), would be sufficient
to stimulate dynein. If so, it would indicate that Lis1 dimerization
is not critical for this function. A polypeptide encompassing the
C-terminal domain of Lis1 was isolated and tested in the ATPase
assay (Fig. 2D). Although this fragment binds dynein, it was not
able to stimulate dynein enzymatic activity. Moreover, the frag-
ment reduced stimulation by full-length Lis1, indicating that it
competed for binding to dynein to block stimulation by Lis1
dimers (Fig. 2D). Based on these findings, we propose that Lis1
dimers are required for dynein stimulation.
Lis1 binds a subset of dynein motors in vitro
The significance of the increase in ATP hydrolysis depends on the
percentage of functional motor complexes that actually bind
Lis1. If all motors interact with Lis1, then Lis1 probably activates
each motor by 40%. In contrast, if only a subset of motors bind
Lis1, 40% could be an underestimate of the “per motor” stimu-
lation. The actual increase would depend on the percentage of
motors that bind Lis1. We used two approaches to estimate the
interaction between Lis1 and dynein in vitro. First, the sedimen-
tation of a Lis1/dynein mixture in a 5–25% sucrose gradient was
compared with that of each protein individually and to sedimen-
tation controls. In the absence of dynein, all of Lis1 was found in
lower density fractions corresponding to a 7S complex (Fig.
3A). Dynein alone was found in denser fractions corresponding
to a 20S complex. When 5 pmol of dynein was mixed with a
threefold molar excess of Lis1, some of the Lis1 shifted to the 20S
portion of the sucrose gradient, where it cofractionated with cy-
toplasmic dynein. The signal density of the precipitated Lis1 was
compared with known amounts of recombinant Lis1. Only 1.67
pmol of Lis1 cosedimented with 5 pmol of dynein, so Lis1 may
bind approximately one-third of the motors.
Comparable results were obtained when dynein was immu-
noprecipitated from a mixture of Lis1 and dynein (Fig. 3B). On
average, 0.37 pmol of Lis1 precipitated with 1 pmol of dynein.
This was not increased by additional Lis1. To determine whether
the degree of interaction was modulated by the nucleotide-
binding status of the motor, we performed immunoprecipita-
tions in the presence of excess ATP or ADP. We found no differ-
ence in the capacity of dynein to interact with Lis1 (Fig. 3C),
indicating that Lis1 binds to dynein throughout the ATP mech-
anochemical cycle.
We also performed immunoprecipitations from the dynein/
Lis1 mix using a Lis1 antibody. When present in equimolar
amounts, 0.37 pmol of dynein coprecipitated per pmol of Lis1
(Fig. 3D). Lis1 binding was saturated in the presence of fourfold
excess dynein; the ratio of Lis1:dynein was 1.2 and 1.3 in the
immunoprecipitations (IPs) with fourfold and eightfold excess
dynein, respectively (Fig. 3E). The data indicate that each Lis1 is
competent to bind dynein, and that Lis1 dimers bind to a single
dynein complex. They further support the hypothesis that ap-
proximately one-third of the dynein motors are competent to
bind to Lis1 in vitro.
Lis1 interacts with a subset of dynein motors in rat tissues
To determine whether the ability of Lis1 to interact with a subset
of dynein complexes is also true in vivo, we immunoprecipitated
dynein from three different adult rat tissue lysates and then esti-
mated the amount of coprecipitated Lis1 compared with a re-
combinant Lis1 standard (Fig. 4A,B). Approximately 5.6 pmol of
dynein coprecipitated 0.2 pmol of Lis1 from brain extracts. This
1:28 molar ratio is lower than that observed in vitro with purified
proteins. Only 2.0 pmol of dynein was precipitated from testes
lysate, but this was associated with 0.2 pmol of Lis1, a 1:10 molar
ratio. No Lis1 was detected in the IP from liver, despite there
being 4 pmol of dynein in the precipitate. Thus, different tissues
Figure 4. Lis1 associates with a subset of dynein complexes in tissue extracts. A, Dynein was
immunoprecipitated from 10 mg of adult rat extract prepared from the indicated tissues using
the 74.1 DIC antibody. Br, Brain; Li, liver; T, testes. Precipitated proteins were visualized by
Western blotting using Lis1 and DIC antibodies. DYN, Purified dynein; Lis1, recombinant Lis1. B,
The data in A were quantified by densitometry, comparing precipitated bands to known
amounts of each protein. The molar amounts were calculated using the Lis1 dimer molecular
weight of 90 kDa and dynein molecular weight of 1.2 MDa. C, The amount of Lis1 and dynein in
soluble extracts and insoluble pellets was compared for each tissue (see Materials and Meth-
ods). All experiments were repeated with similar results. Representative blots or gels are
shown.
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show a different degree of Lis1/dynein interaction, but in all cases,
the proportion of dynein associated with Lis1 was less than that
observed in vitro.
Because all of the active dynein may not be present in our
tissue lysates, we compared the absolute molar ratio of Lis1 to
dynein in insoluble pellets (Fig. 4C) (see Materials and Methods).
Brain contained the highest proportion of insoluble dynein, fol-
lowed by testes and then liver. Insoluble Lis1 was present at an
1:3 molar ratio with dynein in each tissue. This suggests that in
the insoluble fraction, no more than one-
third of dynein motors are associated with
Lis1.
Colocalization of Lis1 and dynein along
microtubules and in growth cones
is variable
Lis1 immunoreactivity is enriched at cen-
trosomes and in punctate structures that
decorate microtubules in Cos-7 cells
(Smith et al., 2000) (Fig. 5A). A similar
pattern is observed using the 74.1 DIC an-
tibody (Fig. 5B). To determine whether
punctate MT-associated Lis1 is associated
with dynein motors, we costained cells for
Lis1 and DIC. In general, the punctate pat-
tern of dynein staining was distinct from
the punctate Lis1 pattern, although both
were observed along the straight and cur-
vilinear paths reminiscent of microtubules
(Fig. 5B, left). When the images were dig-
itally enhanced to increase the visibility of
overlap puncta (see Materials and Meth-
ods), single and double-labeled puncta
could be readily counted (Fig. 5B, right).
On average, only 22% (7.9) of the
dynein-positive puncta were also positive
for Lis1. Although this analysis does not
provide quantitative information at the
molecular level, it supports the idea that
only a subset of active dynein molecules
interact with Lis1. Interestingly, treatment of
Cos-7 cells with 10 M nocodazole to disrupt
microtubules reduced the overlap to 5.6%
(2.5), indicating that some of the overlap-
ping puncta were dependent on the presence
of a microtubule cytoskeleton.
Lis1 is present in neurites and cell bod-
ies in developing stage 2 hippocampal neu-
rons (Fig. 5C, top). Lis1 later accumulates in
the newly emerging axonal growth cone
(Fig. 5C, bottom, arrow) but not in minor
processes. Dynein and Lis1 colocalize in cell
bodies, neurites, and nascent axonal growth
cones (Fig. 5D). A closer view reveals re-
gional variation in the extent of overlap in
neurites and in nascent growth cones,
whereas axonal overlap seems fairly robust
and consistent. This suggests that the inter-
action between Lis1 and dynein may be dy-
namic and highly regulated in growth cones,
and less so in axons.
Discussion
This work establishes Lis1 as a dynein reg-
ulatory protein and links its function to dynein enzymatic activ-
ity. The simplest interpretation of our data is that Lis1 acts spe-
cifically and directly on dynein. Although the increase in ATPase
activity is modest at first glance, our determination that only
one-third of the dynein molecules interacted with Lis1 suggests
that there were two populations of motors present in the ATPase
assay. The major population did not stably bind Lis1 and is not
expected to have had any change in ATPase activity, whereas a
Figure 5. Partial colocalization of Lis1 and dynein. A, Punctate Lis1 immunoreactivity (red) decorates microtubules (green).
Bottom, An enlargement of the region indicated by the arrow. B, Left, This pattern was also seen with Lis1 (red) and dynein
(74.1-green), but the overlap was not extensive. The bottom left panel shows an enlargement of the area in the white square.
Right, To more easily quantify overlap (yellow), deconvolved volumes were inverted and the hues adjusted so that overlapping
puncta were colorized blue (arrows). The bottom middle panel shows an enlargement of the area in the black square. A bar graph
shows the percentage of dynein puncta in control (CON) and nocodazole-treated (NOC.) cells that were also positive for Lis1 (12
cells SD). C, Lis1 immunoreactivity (red) and actin staining (green) in E17 hippocampal neurons. Top, A stage 2 neuron with
undifferentiated neurites. Bottom, A stage 3 neuron with a newly differentiated axonal growth cone enriched in Lis1 (arrow). D,
Top, Dynein (red) and Lis1 (green) immunofluorescence in a stage 4 neuron. Bottom panels show enlargements of the growth
cone (inset) and the axonal region indicated by the arrow. Two distinct regions in the growth cone are further enlarged (1 and 2).
Scale bars: A, B, D, 10 m; C, 5 m.
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smaller population binds Lis1, resulting in a boost in ATPase
activity. In this scenario, the enzymatic activity of the dynein as a
whole would have increased by only 40%, but the activity of
Lis1-associated motors may have increased by 100%.
The finding that Lis1 can stimulate dynein in vitro supports
our model that Lis1 has an activating influence on dynein in cells
(Smith et al., 2000). In our previous work, we found that raising
Lis1 expression levels above that normally found in non-
neuronal cells produced phenotypes suggestive of more active
motors, whereas decreasing Lis1 expression had the opposite ef-
fect. Although altering Lis1 levels could have stimulated or inhib-
ited neuron-like functions of dynein, our new data support a
model in which changing the Lis1:dynein ratio in cells alters the
proportion of dynein that is “stimulated.” Brain and testes con-
tain more Lis1 and more dynein than the liver. The fact that brain
and testes also express more Lis1 relative to dynein indicates that
these tissues contain a higher proportion of Lis1-stimulated
dynein.
The WD domain of Lis1 was not able to activate dynein in
vitro and acted in a dominant-negative manner when pre-
sented along with full-length Lis1. This is particularly inter-
esting in light of a report describing the phenotype of mice
carrying a mutant Lis1 allele and expressing a truncated Lis1
protein similar to our WDLis1 (Cahana et al., 2001). Homozy-
gotic expression of this protein in mice was lethal during the
implantation stage, indicating that dimer formation is impor-
tant for Lis1 function. However, heterozygotes, which ex-
pressed both the truncated protein and full-length Lis1, had
developmental brain abnormalities that were somewhat less
severe than mice with a null mutation in one allele. This could
mean that in mice, the WD domain does not block activation
of dynein by full-length Lis1, and that it may perform some
Lis1 functions. Alternatively, cells may have mechanisms to
compensate for this truncated protein that are not available in
vitro, such as sequestration.
One issue raised by our studies is the nature of events that
regulate the interactions between Lis1 and dynein. Because dy-
nein is heterogeneous, containing the range of isoforms present
in the adult brain, we suspect that Lis1 may preferentially bind to
a specific class of dynein. This could involve posttranslational
modification of dynein or Lis1. We observed no difference in Lis1
binding to dynein treated with  phosphatase, so dynein phos-
phorylation is probably not the determining factor (data not
shown). Our murine Lis1, which was overexpressed in an insect
cell line, is less likely to be posttranslationally modified to the
same extent as native brain protein. However, some differential
modification of Lis1 could conceivably impact binding to dynein.
Another possibility is that Lis1 binding to dynein is blocked by
other proteins; this is unlikely to occur in our in vitro assay in
which we include reasonably purified proteins. An alternate ex-
planation is that specific isoforms of nonheavy chain dynein sub-
units modulate Lis1 binding. Future studies will be needed to
determine whether this is the case. It will also be important to
determine which signaling pathways impact the association of
Lis1 with dynein.
Another issue raised by our studies is the question of whether
Lis1 binding to dynein provides a continuous stimulus or acts as
a trigger. If the latter is true, it does not appear to do so by
increasing the association of dynein with microtubules. A high
Lis1/dynein ratio in the brain and testes could indicate that the
interaction between these proteins needs to be continuously re-
newed to maintain the level of stimulation. Finally, our data in-
dicate that different tissues may use the Lis1 dynein interaction
differently.
Although the demonstration that Lis1 can directly regulate
dynein is extremely interesting, we have only begun to address
the cause and effect relationships between Lis1-induced in-
creases in dynein ATPase activity and changes in cell behavior.
Regardless of how the interaction is regulated, selective stim-
ulation of some dynein isoforms by Lis1 in the nervous system
is likely to be important for retrograde axonal transport and
neuronal migration, processes that are impaired by reduced
Lis1 expression.
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